References
- Burioka N., Suyama H., Sako T., Shimizu E. Circadian rhythm in peak expiratory flow: alteration with nocturnal asthma and theophylline chronotherapy. Chronobiol. Int. 2000; 17: 513–519
- D'Alonzo G. E., Crocetti J. G., Smolensky M. H. Circadian rhythms in the pharmacokinetics and clinical effects of beta‐agonist, theophylline, and anticholinergic medications in the treatment of nocturnal asthma. Chronobiol. Int. 1999; 16: 663–682
- GINA Workshop Report, Global Strategy for Asthma Management and Prevention—updated April. 2002, Scientific information and recommendations for asthma programs. NIH Publication No. 02‐3659
- Halberg F. Quo Vadis Basic and clinical chronobiology: promise for health maintenance. Am. J. Anatomy 1983; 168: 543–594
- Hetzel M. R., Clark T. J. Comparison of normal and asthmatic circadian rhythms in peak expiratory flow rate. Thorax 1980; 35: 732–738
- Hetzel M. R., Clark T. J., Branthwaite M. A. Asthma: analysis of sudden deaths and ventilatory arrests in hospital. Br. Med. J. 1977; 1(6064)808–811
- Horiguchi T., Kondo R., Miyazaki J., Fukumoto K., Torigoe H. Clinical evaluation of a transdermal therapeutic system of the beta2‐agonist tulobuterol in patients with mild or moderate persistent bronchial asthma. Arzneimittelforschung 2004; 54: 280–285
- Iikura Y., Uchiyama H., Akimoto K., Ebisawa M., Sakaguchi N., Tsubaki T., Ishizu H., Kabayama H., Yagi K., Miura K., Onda T. Pharmacokinetics and pharmacodynamics of the tulobuterol patch, HN‐078, in childhood asthma. Ann. Allergy Asthma Immunol. 1995; 74: 147–151
- Jarjour N. N. Circadian variation in allergen and nonspecific bronchial responsiveness in asthma. Chronobiol. Int. 1999; 16: 631–639
- Kume H., Kondo M., Ito Y., Suzuki R., Yamaki K., Takagi K. Effects of sustained‐release tulobuterol on asthma control and beta‐adrenoceptor function. Clin. Exp. Pharmacol. Physiol. 2002; 29: 1076–1083
- Lockey R. F., DuBuske L. M., Friedman B., Petrocella V., Cox F., Rickard K. Nocturnal asthma: effect of salmeterol on quality of life and clinical outcomes. Chest 1999; 115: 666–673
- Martin R. J. Location of airway inflammation in asthma and the relationship to circadian change in lung function. Chronobiol. Int. 1999; 16: 623–630
- Nelson W., Tong Y. L., Lee J., Halberg F. Methods for cosinor‐rhythmometry. Chronobiologia 1979; 6: 305–323
- Shah L., Wilson A. J., Gibson P. G., Coughlan J. Long acting beta‐agonists versus theophylline for maintenance treatment of asthma. Cochrane Database Syst. Rev. 2003, CD001281
- Smolensky M. H., D'Alonzo G. E. Biologic rhythm and medicine. Am. J. Med. 1988; 85(Suppl 1B)34–46
- Smolensky M. H., D'Alonzo G. E. Biological rhythms and medication: chronopharmacology and chronotherapeutics. Nocturnal Asthma. Mechanisms and Treatment, R. J. Martin. Futura Publishing Co., New York 1993; 25–69
- Smolensky M. H., Reinberg A. E., Martin R. J., Haus E. Clinical chronobiology and chronotherapeutics with applications to asthma. Chronobiol. Int. 1999; 16: 539–563
- Touitou Y., Portaluppi F., Smolensky M. H., Rensing L. Ethical principles and standards for the conduct of human and animal biological rhythm research. Chronobiol. Int. 2004; 21: 161–170
- Turner‐Warwick M. On observing patterns of airflow obstruction in chronic asthma. Br. J. Dis. Chest. 1977; 71: 73–86
- Uematsu T., Nakano M., Kosuge M., Kanamura M., Nakashima M. The pharmacokinetics of β2‐adrenoceptor agonist, tulobuterol, given transdermally and by inhalation. Eur. J. Clin. Pharmacol. 1993; 44: 361–364